Vânia Palma Roberto
Vânia Palma Roberto has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
- Maria Leonor Cancela
Centre of Marine Sciences, University of Algarve, 8005-139 Faro, Portugal
11 shared publications - Daniel Martins Tiago
Centre of Marine Sciences (CCMAR), University of Algarve, Faro, Portugal
5 shared publications - Paulo Jorge Gavaia
Center of Marine Sciences, University of Algarve, Faro, Portugal
5 shared publications - Pedro Castelo-Branco
Faculty of Medicine and Biomedical Sciences, University of Algarve, 8005-139 Faro, Portugal
5 shared publications - Vincent Laizé
Centre of Marine Sciences, University of Algarve, 8005-139 Faro, Portugal
4 shared publications - Joana Dias Apolónio
Faculty of Medicine and Biomedical Sciences (FMCB), University of Algarve, Gambelas Campus, Bld. 2, 8005-139 Faro, Portugal
3 shared publications
Latest Publications
- Open Access
- 13 July 2023
- Published by Springer Nature in Biogerontology
- Vol. 24 (6) , 845-866
Measuring healthy ageing: current and future tools
Human ageing is a complex, multifactorial process characterised by physiological damage, increased risk of age-related diseases and inevitable functional deterioration. As the population of the world grows older, placing significant strain on social and healthcare resources, there is a growing need to identify reliable and easy-to-employ markers of healthy ageing for early detection of ageing trajectories and disease risk. Such markers would allow for the targeted implementation of strategies or treatments that can lessen suffering, disability, and dependence in old age. In this review, we summarise the healthy ageing scores reported in the literature, with a focus on the past 5 years, and compare and contrast the variables employed. The use of approaches to determine biological age, molecular biomarkers, ageing trajectories, and multi-omics ageing scores are reviewed. We conclude that the ideal healthy ageing score is multisystemic and able to encompass all of the potential alterations associated with ageing. It should also be longitudinal and able to accurately predict ageing complications at an early stage in order to maximize the chances of successful early intervention.
- 13 July 2023
- Published by Springer Nature in Biogerontology
- Vol. 24 (6) , 845-866
Open AccessMeasuring healthy ageing: current and future tools
Human ageing is a complex, multifactorial process characterised by physiological damage, increased risk of age-related diseases and inevitable functional deterioration. As the population of the world grows older, placing significant strain on social and healthcare resources, there is a growing need to identify reliable and easy-to-employ markers of healthy ageing for early detection of ageing trajectories and disease risk. Such markers would allow for the targeted implementation of strategies or treatments that can lessen suffering, disability, and dependence in old age. In this review, we summarise the healthy ageing scores reported in the literature, with a focus on the past 5 years, and compare and contrast the variables employed. The use of approaches to determine biological age, molecular biomarkers, ageing trajectories, and multi-omics ageing scores are reviewed. We conclude that the ideal healthy ageing score is multisystemic and able to encompass all of the potential alterations associated with ageing. It should also be longitudinal and able to accurately predict ageing complications at an early stage in order to maximize the chances of successful early intervention.
- Open Access
DNA Methylation of PI3K/AKT Pathway-Related Genes Predicts Outcome in Patients with Pancreatic Cancer: A Comprehensive Bioinformatics-Based Study
Pancreatic cancer (PCA) is one of the most lethal malignancies worldwide with a 5-year survival rate of 9%. Despite the advances in the field, the need for an earlier detection and effective therapies is paramount. PCA high heterogeneity suggests that epigenetic alterations play a key role in tumour development. However, only few epigenetic biomarkers or therapeutic targets have been identified so far. Here we explored the potential of distinct DNA methylation signatures as biomarkers for early detection and prognosis of PCA. PI3K/AKT-related genes differentially expressed in PCA were identified using the Pancreatic Expression Database (n = 153). Methylation data from PCA patients was obtained from The Cancer Genome Atlas (n = 183), crossed with clinical data to evaluate the biomarker potential of the epigenetic signatures identified and validated in independent cohorts. The majority of selected genes presented higher expression and hypomethylation in tumour tissue. The methylation signatures of specific genes in the PI3K/AKT pathway could distinguish normal from malignant tissue at initial disease stages with AUC > 0.8, revealing their potential as PCA diagnostic tools. ITGA4, SFN, ITGA2, and PIK3R1 methylation levels could be independent prognostic indicators of patients’ survival. Methylation status of SFN and PIK3R1 were also associated with disease recurrence. Our study reveals that the methylation levels of PIK3/AKT genes involved in PCA could be used to diagnose and predict patients’ clinical outcome with high sensitivity and specificity. These results provide new evidence of the potential of epigenetic alterations as biomarkers for disease screening and management and highlight possible therapeutic targets.
Open AccessDNA Methylation of PI3K/AKT Pathway-Related Genes Predicts Outcome in Patients with Pancreatic Cancer: A Comprehensive Bioinformatics-Based Study
Pancreatic cancer (PCA) is one of the most lethal malignancies worldwide with a 5-year survival rate of 9%. Despite the advances in the field, the need for an earlier detection and effective therapies is paramount. PCA high heterogeneity suggests that epigenetic alterations play a key role in tumour development. However, only few epigenetic biomarkers or therapeutic targets have been identified so far. Here we explored the potential of distinct DNA methylation signatures as biomarkers for early detection and prognosis of PCA. PI3K/AKT-related genes differentially expressed in PCA were identified using the Pancreatic Expression Database (n = 153). Methylation data from PCA patients was obtained from The Cancer Genome Atlas (n = 183), crossed with clinical data to evaluate the biomarker potential of the epigenetic signatures identified and validated in independent cohorts. The majority of selected genes presented higher expression and hypomethylation in tumour tissue. The methylation signatures of specific genes in the PI3K/AKT pathway could distinguish normal from malignant tissue at initial disease stages with AUC > 0.8, revealing their potential as PCA diagnostic tools. ITGA4, SFN, ITGA2, and PIK3R1 methylation levels could be independent prognostic indicators of patients’ survival. Methylation status of SFN and PIK3R1 were also associated with disease recurrence. Our study reveals that the methylation levels of PIK3/AKT genes involved in PCA could be used to diagnose and predict patients’ clinical outcome with high sensitivity and specificity. These results provide new evidence of the potential of epigenetic alterations as biomarkers for disease screening and management and highlight possible therapeutic targets.
- Open Access
- 21 September 2021
- Published by Impact Journals, LLC in Aging
- Vol. 13 (18) , 21991-22029
Identification of colorectal cancer associated biomarkers: an integrated analysis of miRNA expression
Colorectal cancer is one of the leading causes of cancer-related deaths worldwide. This complex disease still holds severe problems concerning diagnosis due to the high invasiveness nature of colonoscopy and the low accuracy of the alternative diagnostic methods. Additionally, patient heterogeneity even within the same stage is not properly reflected in the current stratification system. This scenario highlights the need for new biomarkers to improve non-invasive screenings and clinical management of patients.
- 21 September 2021
- Published by Impact Journals, LLC in Aging
- Vol. 13 (18) , 21991-22029
Open AccessIdentification of colorectal cancer associated biomarkers: an integrated analysis of miRNA expression
Colorectal cancer is one of the leading causes of cancer-related deaths worldwide. This complex disease still holds severe problems concerning diagnosis due to the high invasiveness nature of colonoscopy and the low accuracy of the alternative diagnostic methods. Additionally, patient heterogeneity even within the same stage is not properly reflected in the current stratification system. This scenario highlights the need for new biomarkers to improve non-invasive screenings and clinical management of patients.
- 29 January 2019
- Published by Taylor & Francis in Future Oncology
- Vol. 15 (7) , 683-685
Hot Topics in Epigenetic Regulation of Cancer Self-Renewal for Pancreatic Tumors: Future Trends
- 29 January 2019
- Published by Taylor & Francis in Future Oncology
- Vol. 15 (7) , 683-685
Hot Topics in Epigenetic Regulation of Cancer Self-Renewal for Pancreatic Tumors: Future Trends
- 1 January 2019
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 1863 (1) , 39-51
Circulating small non-coding RNAs provide new insights into vitamin K nutrition and reproductive physiology in teleost fish
- 1 January 2019
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 1863 (1) , 39-51
Circulating small non-coding RNAs provide new insights into vitamin K nutrition and reproductive physiology in teleost fish
- 28 February 2018
- Published by Hindawi Limited in Journal of Applied Ichthyology
- Vol. 34 (2) , 512-523
Insights from dietary supplementation with zinc and strontium on the skeleton of zebrafish,Danio rerio(Hamilton, 1822) larvae: From morphological analysis to osteogenic markers
In order to obtain additional insights into the zinc (Zn) and strontium (Sr) effects on bone formation, the zebrafish (Danio rerio) was used as a recognized model for vertebrate skeletogenesis. The treatments began 5 days post‐fertilization, using triplicates for each test condition, with 100 larvae per replicate for the strontium trials and 80 larvae per replicate for the zinc trials. Tanks were maintained at 28 ºC with a temperature and photoperiod control (recirculation system ZebTECH, Tecniplast). Diets for the zebrafish larvae undergoing vertebrae formation and mineralization (from 5 to 30 dpf) were supplemented with increasing concentrations of either zinc sulfate or strontium citrate, as sources of Zn or Sr, respectively, and their effects on the fish skeleton were evaluated at both histomorphological and molecular levels. Whereas high amounts of Zn (240 and 480 mg/kg) increased larvae mortality, intermediate amounts (60 to 120 mg/kg) gave similar results as the control diet regarding deformities, suggesting that these amounts are not detrimental to development of the larvae skeleton. In addition, osteogenic markers runx2, sp7 and oc were increased by Zn supplementation, indicating that appropriate amounts of Zn seem to support bone formation in zebrafish larvae. In Sr experiments, two Sr concentrations and two bio‐encapsulation materials were evaluated: chitosan and ĸ‐carrageenan. Interestingly, Sr bio‐encapsulation with chitosan decreased the number of deformed larvae and the number of deformities per larvae at 2500 mg/kg, while ĸ‐carrageenan encapsulation failed to produce any positive effects. Furthermore, the chitosan experimental groups presented an increased expression of the osteoblast differentiation markers, sp7 and oc, suggesting that Sr promotes osteoblast differentiation and bone formation in zebrafish larvae.
- 28 February 2018
- Published by Hindawi Limited in Journal of Applied Ichthyology
- Vol. 34 (2) , 512-523
Insights from dietary supplementation with zinc and strontium on the skeleton of zebrafish,Danio rerio(Hamilton, 1822) larvae: From morphological analysis to osteogenic markers
In order to obtain additional insights into the zinc (Zn) and strontium (Sr) effects on bone formation, the zebrafish (Danio rerio) was used as a recognized model for vertebrate skeletogenesis. The treatments began 5 days post‐fertilization, using triplicates for each test condition, with 100 larvae per replicate for the strontium trials and 80 larvae per replicate for the zinc trials. Tanks were maintained at 28 ºC with a temperature and photoperiod control (recirculation system ZebTECH, Tecniplast). Diets for the zebrafish larvae undergoing vertebrae formation and mineralization (from 5 to 30 dpf) were supplemented with increasing concentrations of either zinc sulfate or strontium citrate, as sources of Zn or Sr, respectively, and their effects on the fish skeleton were evaluated at both histomorphological and molecular levels. Whereas high amounts of Zn (240 and 480 mg/kg) increased larvae mortality, intermediate amounts (60 to 120 mg/kg) gave similar results as the control diet regarding deformities, suggesting that these amounts are not detrimental to development of the larvae skeleton. In addition, osteogenic markers runx2, sp7 and oc were increased by Zn supplementation, indicating that appropriate amounts of Zn seem to support bone formation in zebrafish larvae. In Sr experiments, two Sr concentrations and two bio‐encapsulation materials were evaluated: chitosan and ĸ‐carrageenan. Interestingly, Sr bio‐encapsulation with chitosan decreased the number of deformed larvae and the number of deformities per larvae at 2500 mg/kg, while ĸ‐carrageenan encapsulation failed to produce any positive effects. Furthermore, the chitosan experimental groups presented an increased expression of the osteoblast differentiation markers, sp7 and oc, suggesting that Sr promotes osteoblast differentiation and bone formation in zebrafish larvae.
- Open Access
- 27 February 2018
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 1-16
Evidences for a New Role of miR-214 in Chondrogenesis
MiR-214 is known to play a role in mammalian skeletal development through inhibition of osteogenesis and stimulation of osteoclastogenesis, but data regarding other vertebrates, as well as a possible role in chondrogenesis, remain unknown. Here, we show that miR-214 expression is detected in bone and cartilage of zebrafish skeleton, and is downregulated during murine ATDC5 chondrocyte differentiation. Additionally, we observed a conservation of the transcriptional regulation of miR-214 primary transcript Dnm3os in vertebrates, being regulated by Ets1 in ATDC5 chondrogenic cells. Moreover, overexpression of miR-214 in vitro and in vivo mitigated chondrocyte differentiation probably by targeting activating transcription factor 4 (Atf4). Indeed, miR-214 overexpression in vivo hampered cranial cartilage formation of zebrafish and coincided with downregulation of atf4 and of the key chondrogenic players sox9 and col2a1. We show that miR-214 overexpression exerts a negative role in chondrogenesis by impacting on chondrocyte differentiation possibly through conserved mechanisms.
- 27 February 2018
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 1-16
Open AccessEvidences for a New Role of miR-214 in Chondrogenesis
MiR-214 is known to play a role in mammalian skeletal development through inhibition of osteogenesis and stimulation of osteoclastogenesis, but data regarding other vertebrates, as well as a possible role in chondrogenesis, remain unknown. Here, we show that miR-214 expression is detected in bone and cartilage of zebrafish skeleton, and is downregulated during murine ATDC5 chondrocyte differentiation. Additionally, we observed a conservation of the transcriptional regulation of miR-214 primary transcript Dnm3os in vertebrates, being regulated by Ets1 in ATDC5 chondrogenic cells. Moreover, overexpression of miR-214 in vitro and in vivo mitigated chondrocyte differentiation probably by targeting activating transcription factor 4 (Atf4). Indeed, miR-214 overexpression in vivo hampered cranial cartilage formation of zebrafish and coincided with downregulation of atf4 and of the key chondrogenic players sox9 and col2a1. We show that miR-214 overexpression exerts a negative role in chondrogenesis by impacting on chondrocyte differentiation possibly through conserved mechanisms.
- 11 October 2017
- Published by Taylor & Francis in Future Oncology
- Vol. 13 (23) , 2045-2051
The TERT hypermethylated oncologic region predicts recurrence and survival in pancreatic cancer
Aim: We explore the biomarker potential of the TERT hypermethylated oncologic region (THOR) in pancreatic cancer. Materials & methods: We assessed the methylation status of THOR using the cancer genome atlas data on the cohort of pancreatic cancer (n = 193 patients). Results: THOR was significantly hypermethylated in pancreatic tumor tissue when compared with the normal tissue used as control (p < 0.0001). Also, THOR hypermethylation could distinguish early stage I disease from normal tissue and was associated with worse prognosis. Discussion: We found that THOR is hypermethylated in pancreatic tumor tissue when compared with normal tissue and that THOR methylation correlates with TERT expression in tumor samples. Conclusion: Our preliminary findings support the diagnostic and prognostic values of THOR in pancreatic cancer. Graphical abstract
- 11 October 2017
- Published by Taylor & Francis in Future Oncology
- Vol. 13 (23) , 2045-2051
The TERT hypermethylated oncologic region predicts recurrence and survival in pancreatic cancer
Aim: We explore the biomarker potential of the TERT hypermethylated oncologic region (THOR) in pancreatic cancer. Materials & methods: We assessed the methylation status of THOR using the cancer genome atlas data on the cohort of pancreatic cancer (n = 193 patients). Results: THOR was significantly hypermethylated in pancreatic tumor tissue when compared with the normal tissue used as control (p < 0.0001). Also, THOR hypermethylation could distinguish early stage I disease from normal tissue and was associated with worse prognosis. Discussion: We found that THOR is hypermethylated in pancreatic tumor tissue when compared with normal tissue and that THOR methylation correlates with TERT expression in tumor samples. Conclusion: Our preliminary findings support the diagnostic and prognostic values of THOR in pancreatic cancer. Graphical abstract
- Open Access
- 1 September 2017
- Published by Elsevier in Marine Environmental Research
- Vol. 130, 187-199
The xenobiotic sensor PXR in a marine flatfish species (Solea senegalensis): Gene expression patterns and its regulation under different physiological conditions
- 1 September 2017
- Published by Elsevier in Marine Environmental Research
- Vol. 130, 187-199
Open AccessThe xenobiotic sensor PXR in a marine flatfish species (Solea senegalensis): Gene expression patterns and its regulation under different physiological conditions
- 20 May 2017
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 35 (15_suppl) , e15717
Epigenetic regulation of cancer self-renewal differs between endocrine tumors.
E15717 Background: Cancer cells achieve limitless self-renewal capacity mainly through telomerase reactivation. Methylation of a specific region in the h TERT promoter, termed TERT Hypermethylated Oncologic Region (THOR), has been associated with telomerase reactivation, increased telomerase activity and patient outcome in several cancers. Methods: In this study, we assessed the methylation status of THOR using The Cancer Genome Atlas (TCGA) data on cohorts of two endocrine cancers with distinct cell proliferation rates: the highly proliferative pancreatic adenocarcinoma (n = 194 patients) and the more indolent thyroid carcinoma (n = 571 patients). Results: THOR was significantly hypermethylated in malignant cancer when compared to benign adjacent tissue in pancreatic cancer (p < 0.0001), but not in thyroid cancer. In pancreatic cancer, THOR hypermethylation could also distinguish normal tissue from early stage I disease and it associated with worst patient prognosis. Conclusions: These preliminary findings indicate that THOR can discriminate aggressive tumors from non-aggressive ones, and evidenced the diagnostic and prognostic value of THOR in pancreatic cancer.
- 20 May 2017
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 35 (15_suppl) , e15717
Epigenetic regulation of cancer self-renewal differs between endocrine tumors.
E15717 Background: Cancer cells achieve limitless self-renewal capacity mainly through telomerase reactivation. Methylation of a specific region in the h TERT promoter, termed TERT Hypermethylated Oncologic Region (THOR), has been associated with telomerase reactivation, increased telomerase activity and patient outcome in several cancers. Methods: In this study, we assessed the methylation status of THOR using The Cancer Genome Atlas (TCGA) data on cohorts of two endocrine cancers with distinct cell proliferation rates: the highly proliferative pancreatic adenocarcinoma (n = 194 patients) and the more indolent thyroid carcinoma (n = 571 patients). Results: THOR was significantly hypermethylated in malignant cancer when compared to benign adjacent tissue in pancreatic cancer (p < 0.0001), but not in thyroid cancer. In pancreatic cancer, THOR hypermethylation could also distinguish normal tissue from early stage I disease and it associated with worst patient prognosis. Conclusions: These preliminary findings indicate that THOR can discriminate aggressive tumors from non-aggressive ones, and evidenced the diagnostic and prognostic value of THOR in pancreatic cancer.